The collective message from the in vitro and in vivo studies is thus that Ab-A has the unique dual mode of action of neuroprotection and amyloid debulking, which translates into improvement of the motoric function in a model of neuropathy inducible by human TTR amyloid extract. Here, TTR is linked to amyloidosis.